Stockscreener 앱 받기
157.16
2.85%
4.36
시간 외 거래:
156.96
-0.20
-0.13%
전일 마감가:
$152.80
열려 있는:
$153
하루 거래량:
3.49M
Relative Volume:
1.36
시가총액:
$33.22B
수익:
$398.11M
순이익/손실:
$-1.03B
주가수익비율:
-27.56
EPS:
-5.7032
순현금흐름:
$-868.57M
1주 성능:
+14.69%
1개월 성능:
+9.52%
6개월 성능:
+114.32%
1년 성능:
+120.11%
1일 변동 폭
$151.77
$158.19
1주일 범위
$136.62
$158.19
52주 변동 폭
$60.40
$158.19
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
157.16 | 32.30B | 398.11M | -1.03B | -868.57M | -5.7032 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.30 | 104.83B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.00 | 63.59B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.35 | 60.43B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
800.00 | 48.45B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
343.87 | 37.91B | 4.56B | -176.77M | 225.30M | -1.7177 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-20 | 개시 | William Blair | Outperform |
| 2025-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
How Analysts Are Rethinking Insmed After Brinsupri’s Approval and New Revenue Projections - Yahoo Finance
Goldman Sachs Maintains Insmed (INSM) Buy Recommendation - Nasdaq
Goldman Sachs Raises Insmed (INSM) Price Target to $196 | INSM Stock News - GuruFocus
Real time breakdown of Insmed Incorporated stock performanceEarnings Recap Report & Fast Gaining Stock Reports - newser.com
Is Insmed Incorporated (IM8N) stock bottoming after sell offJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com
How Insmed Incorporated (IM8N) stock performs during market turbulenceJuly 2025 Big Picture & Technical Buy Zone Confirmations - newser.com
GAMMA Investing LLC Cuts Stock Holdings in Insmed, Inc. $INSM - Defense World
Insmed (NASDAQ:INSM) Given New $193.00 Price Target at TD Cowen - Defense World
Insmed (NASDAQ:INSM) Reaches New 12-Month High on Analyst Upgrade - Defense World
Insmed stock hits 52-week high at 149.2 USD By Investing.com - Investing.com Nigeria
TD Cowen Raises Price Target for Insmed (INSM) to $193 | INSM St - GuruFocus
Ohio Retirement Fund Invests in Insmed Incorporated (INSM) - Yahoo Finance
Insmed, Inc. Hits Day High with Strong 5.09% Intraday Surge - Markets Mojo
Insmed: De-Risked Respiratory Growth, Premium Multiple, And Real M&A Optionality - Seeking Alpha
Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9% - Yahoo Finance
S&P 500 Futures Decline in Premarket Trading; Firefly Aerospace, Insmed Lag - Barron's
How buyback programs support Insmed Incorporated (IM8N) stockShort Setup & AI Enhanced Trade Execution Alerts - newser.com
Public Employees Retirement System of Ohio Makes New Investment in Insmed, Inc. $INSM - MarketBeat
Goldman's 48 potential M&A candidates (INSM:NASDAQ) - Seeking Alpha
Is Insmed Incorporated a good long term investmentSector Performance Review & Build Winning Portfolio - earlytimes.in
Insmed Incorporated Stock Analysis and ForecastInsider Trading Compliance & Access Free Tools and Start Investing - Early Times
Insmed Incorporated stock trendline breakdown2025 Big Picture & Safe Entry Zone Identification - newser.com
RBC Capital Remains Bullish on Insmed Incorporated (INSM) - Yahoo Finance
Assenagon Asset Management S.A. Buys 33,626 Shares of Insmed, Inc. $INSM - MarketBeat
Longboard Asset Management LP Acquires New Position in Insmed, Inc. $INSM - MarketBeat
Insmed Incorporated to Present Multiple Abstracts At the European Respiratory Society Congress 2025 - MarketScreener
Cystic Fibrosis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Insmed Inc, AstraZeneca, Zambon, CSL Behring, Chiesi Farmaceutici - The Globe and Mail
Insmed to Present Phase 2b TPIP and Phase 3 ASPEN Trial Data at ERS Congress 2025 - geneonline.com
Insmed (INSM) Highlights Phase 2 and Phase 3 Trial Data at ERS 2025 Congress - GuruFocus
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025 - PR Newswire
Harbor Capital Advisors Inc. Sells 26,030 Shares of Insmed, Inc. $INSM - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Makes New $452,000 Investment in Insmed, Inc. $INSM - MarketBeat
Late-Breaking PAH Treatment Data: Insmed's TPIP Phase 2b Results Lead 7 Presentations at ERS Congress 2025 - Stock Titan
Weekly Trades: Will Insmed Incorporated outperform its industry peersMarket Activity Report & Risk Controlled Daily Plans - خودرو بانک
Strs Ohio Purchases Shares of 25,700 Insmed, Inc. $INSM - MarketBeat
Dividend Watch: Whats the beta of Insmed Incorporated stockMarket Trend Summary & Precise Swing Trade Alerts - خودرو بانک
Rep. Gilbert Ray Cisneros, Jr. Sells Insmed, Inc. (NASDAQ:INSM) Shares - MarketBeat
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.38%
0.94%
자본화:
|
볼륨(24시간):